# Cost Effectiveness of Once-Daily Oral Chelation Therapy with Deferasirox versus Infusional Deferoxamine in Transfusion-Dependent Thalassaemia Patients

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/cost-effectiveness-of-once-daily-oral-chelation-therapy-with-deferasirox-versus/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Thomas E. Delea,Oleg Sofrygin,Simu K. Thomas,Jean‐François Baladi,Pradyumna D. Phatak,Thomas D. Coates |
| Citations | 81 |
| DOI | 10.2165/00019053-200725040-00005 |
| Fields | Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W2062919513 |
| PMID | 17402805 |
| Type | article |
| Year | 2007 |

## Paper authors

- [Simu K. Thomas](https://scholariq.org/researchers/simu-k-thomas/)

## Paper journal

- [PharmacoEconomics](https://scholariq.org/journals/pharmacoeconomics/)

## Paper primary topic

- [Hemoglobinopathies and Related Disorders](https://scholariq.org/topics/hemoglobinopathies-and-related-disorders/)

## Paper topics

- [Hemoglobinopathies and Related Disorders](https://scholariq.org/topics/hemoglobinopathies-and-related-disorders/)
- [Iron Metabolism and Disorders](https://scholariq.org/topics/iron-metabolism-and-disorders/)
- [Erythropoietin and Anemia Treatment](https://scholariq.org/topics/erythropoietin-and-anemia-treatment/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.